semaglutide cardiovascular outcomes trial Summary of the main of the SUSTAIN-6 Timeline of cardiovascular outcome trials

Most people exploring treatment at a medical weight loss clinic hear about therapies like semaglutide for weight loss (GLP-1based) and tirzepatide weight loss programs (GLP-1 + GIP-based)

7.2 Personalized treatment and precision medicine One of the challenges of targeted gut microbiome therapy is the need for personalized treatment

On Thursday, the Food and Drug Administration said Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro to treat diabetes, is no longer in short supply

Studies indicate that patients taking semaglutide often experience reductions in both LDL (bad) cholesterol and triglycerides, particularly when weight loss is achieved